Ameriprise Financial Inc Ani Pharmaceuticals Inc Transaction History

Ameriprise Financial Inc

$381 Billion
Q3 2024

A detailed history of Ameriprise Financial Inc transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Ameriprise Financial Inc holds 237,219 shares of ANIP stock, worth $13.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

237,219

Previous 233,354 1.66%

Holding current value

$13.4 Million

Previous $14.9 Million 4.76%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$54.33 - $65.72 $209,985 - $254,007	3,865 Added 1.66%	237,219 $14.2 Million
Q2 2024 Aug 14, 2024	SELL	$58.53 - $68.82 $580,617 - $682,694	-9,920 Reduced 4.08%	233,354 $14.9 Million
Q1 2024 May 15, 2024	BUY	$54.2 - $69.69 $372,896 - $479,467	6,880 Added 2.91%	243,274 $16.8 Million
Q4 2023 Feb 14, 2024	SELL	$48.72 - $65.43 $536,845 - $720,973	-11,019 Reduced 4.45%	236,394 $13 Million
Q3 2023 Nov 14, 2023	SELL	$50.28 - $64.61 $527,889 - $678,340	-10,499 Reduced 4.07%	247,413 $14.4 Million
Q2 2023 Aug 14, 2023	SELL	$37.29 - $53.83 $1.63 Million - $2.35 Million	-43,653 Reduced 14.48%	257,912 $13.9 Million
Q1 2023 May 15, 2023	SELL	$37.61 - $45.72 $1,128 - $1,371	-30 Reduced 0.01%	301,565 $12 Million
Q4 2022 Feb 14, 2023	SELL	$31.9 - $41.95 $147,218 - $193,599	-4,615 Reduced 1.51%	301,595 $12.1 Million
Q3 2022 Nov 14, 2022	BUY	$29.83 - $38.01 $80,600 - $102,703	2,702 Added 0.89%	306,210 $9.84 Million
Q2 2022 Aug 15, 2022	SELL	$23.09 - $33.46 $230,091 - $333,428	-9,965 Reduced 3.18%	303,508 $9.01 Million
Q1 2022 May 16, 2022	BUY	$26.91 - $47.15 $817,956 - $1.43 Million	30,396 Added 10.74%	313,473 $8.81 Million
Q4 2021 Feb 14, 2022	BUY	$32.97 - $56.85 $301,082 - $519,154	9,132 Added 3.33%	283,077 $13 Million
Q3 2021 Nov 15, 2021	SELL	$26.48 - $35.99 $35,006 - $47,578	-1,322 Reduced 0.48%	273,945 $8.99 Million
Q2 2021 Aug 16, 2021	BUY	$31.86 - $38.6 $1.02 Million - $1.23 Million	31,934 Added 13.12%	275,267 $9.65 Million
Q1 2021 May 17, 2021	BUY	$28.4 - $36.14 $275,110 - $350,088	9,687 Added 4.15%	243,333 $8.8 Million
Q4 2020 Feb 12, 2021	BUY	$23.69 - $31.47 $589,241 - $782,753	24,873 Added 11.91%	233,646 $6.79 Million
Q3 2020 Nov 16, 2020	BUY	$26.38 - $33.1 $4.09 Million - $5.14 Million	155,208 Added 289.76%	208,773 $5.89 Million
Q2 2020 Aug 14, 2020	SELL	$29.93 - $50.1 $92,124 - $154,207	-3,078 Reduced 5.43%	53,565 $1.73 Million
Q1 2020 May 15, 2020	BUY	$30.35 - $67.14 $46,010 - $101,784	1,516 Added 2.75%	56,643 $2.31 Million
Q4 2019 Feb 14, 2020	SELL	$55.65 - $79.83 $129,720 - $186,083	-2,331 Reduced 4.06%	55,127 $3.4 Million
Q3 2019 Nov 14, 2019	SELL	$64.7 - $85.39 $3.55 Million - $4.68 Million	-54,803 Reduced 48.82%	57,458 $4.19 Million
Q2 2019 Aug 14, 2019	SELL	$67.77 - $82.2 $347,660 - $421,686	-5,130 Reduced 4.37%	112,261 $9.23 Million
Q1 2019 May 15, 2019	SELL	$45.83 - $70.54 $786,992 - $1.21 Million	-17,172 Reduced 12.76%	117,391 $8.28 Million
Q4 2018 Feb 14, 2019	SELL	$41.17 - $56.44 $250,931 - $344,001	-6,095 Reduced 4.33%	134,563 $6.06 Million
Q3 2018 Nov 14, 2018	BUY	$52.95 - $71.34 $3.05 Million - $4.1 Million	57,533 Added 69.21%	140,658 $7.95 Million
Q2 2018 Aug 14, 2018	BUY	$56.38 - $68.08 $1.63 Million - $1.97 Million	28,896 Added 53.29%	83,125 $5.55 Million
Q1 2018 May 15, 2018	BUY	$56.98 - $72.41 $67,464 - $85,733	1,184 Added 2.23%	54,229 $3.16 Million
Q4 2017 Feb 12, 2018	SELL	$53.3 - $74.56 $38,109 - $53,310	-715 Reduced 1.33%	53,045 $3.42 Million
Q3 2017 Nov 07, 2017	BUY	$43.46 - $52.49 $2.34 Million - $2.82 Million	53,760	53,760 $2.82 Million

Others Institutions Holding ANIP

# of Institutions

212

Shares Held

18.8M

Call Options Held

11.7K

Put Options Held

10.5K

View Full List

About ANI PHARMACEUTICALS INC

Ticker ANIP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 17,426,000
Market Cap $982M
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...

More about ANIP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account

Ameriprise Financial Inc Ani Pharmaceuticals Inc Transaction History